These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 21478481)

  • 1. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
    Kawarazaki H; Ando K; Fujita M; Matsui H; Nagae A; Muraoka K; Kawarasaki C; Fujita T
    Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1402-9. PubMed ID: 21478481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid receptor--Rac1 activation and oxidative stress play major roles in salt-induced hypertension and kidney injury in prepubertal rats.
    Kawarazaki H; Ando K; Shibata S; Muraoka K; Fujita M; Kawarasaki C; Fujita T
    J Hypertens; 2012 Oct; 30(10):1977-85. PubMed ID: 22914542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
    Kawarazaki H; Ando K; Nagae A; Fujita M; Matsui H; Fujita T
    Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress.
    Nagase M; Matsui H; Shibata S; Gotoda T; Fujita T
    Hypertension; 2007 Nov; 50(5):877-83. PubMed ID: 17875821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA; Mann G; Walton M; Eatman D
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats; renoprotective effects of an ultrahigh dose of olmesartan.
    Fan YY; Baba R; Nagai Y; Miyatake A; Hosomi N; Kimura S; Sun GP; Kohno M; Fujita M; Abe Y; Nishiyama A
    Hypertens Res; 2006 Mar; 29(3):169-78. PubMed ID: 16755152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
    Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T
    J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prepubertal angiotensin blockade exerts long-term therapeutic effect through sustained ATRAP activation in salt-sensitive hypertensive rats.
    Dejima T; Tamura K; Wakui H; Maeda A; Ohsawa M; Kanaoka T; Haku S; Kengo A; Masuda S; Shigenaga A; Azuma K; Matsuda M; Yabana M; Hirose T; Uchino K; Kimura K; Nagashima Y; Umemura S
    J Hypertens; 2011 Oct; 29(10):1919-29. PubMed ID: 21844822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive and cardiorenal protective effects of SM-368229, a novel mineralocorticoid receptor antagonist, in aldosterone/salt-treated rats.
    Nariai T; Fujita K; Mori M; Katayama S; Hori S; Matsui K
    Pharmacology; 2012; 89(1-2):44-52. PubMed ID: 22302095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation.
    Kawarazaki W; Nagase M; Yoshida S; Takeuchi M; Ishizawa K; Ayuzawa N; Ueda K; Fujita T
    J Am Soc Nephrol; 2012 Jun; 23(6):997-1007. PubMed ID: 22440899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
    Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
    Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
    Hirono Y; Yoshimoto T; Suzuki N; Sugiyama T; Sakurada M; Takai S; Kobayashi N; Shichiri M; Hirata Y
    Endocrinology; 2007 Apr; 148(4):1688-96. PubMed ID: 17218415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
    Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
    Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
    Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of brain aldosterone and mineralocorticoid receptors in aldosterone-salt hypertension in rats.
    Wang HW; Huang BS; Chen A; Ahmad M; White RA; Leenen FH
    Neuroscience; 2016 Feb; 314():90-105. PubMed ID: 26656220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone/Mineralocorticoid receptor stimulation induces cellular senescence in the kidney.
    Fan YY; Kohno M; Hitomi H; Kitada K; Fujisawa Y; Yatabe J; Yatabe M; Felder RA; Ohsaki H; Rafiq K; Sherajee SJ; Noma T; Nishiyama A; Nakano D
    Endocrinology; 2011 Feb; 152(2):680-8. PubMed ID: 21190955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
    Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.